ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Revenue

ReShape Lifesciences had revenue of $1.11M in the quarter ending March 31, 2025, a decrease of -42.75%. This brings the company's revenue in the last twelve months to $7.18M, down -13.92% year-over-year. In the year 2024, ReShape Lifesciences had annual revenue of $8.01M, down -7.74%.

• Revenue (ttm): $7.18M
• Revenue Growth: -13.92%
• P/S Ratio: 0.02
• Revenue / Employee: $398,611
• Employees: 18
• Market Cap: 8.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.01M	-672.00K	-7.74%
Dec 31, 2023	8.68M	-2.56M	-22.79%
Dec 31, 2022	11.24M	-2.36M	-17.35%
Dec 31, 2021	13.60M	2.30M	20.36%
Dec 31, 2020	11.30M	-3.79M	-25.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.